315 related articles for article (PubMed ID: 29990852)
1. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
2. The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Świątek P; Majkowski M; Wesołowska O
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813251
[TBL] [Abstract][Full Text] [Related]
3. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
4. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and multidrug resistance reversal activity of phenothiazine derivative is strongly enhanced by theobromine, a phytochemical from cocoa.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Poła A; Dzięgiel P; Puła B; Świątek P; Wesołowska O
Eur J Pharmacol; 2019 Apr; 849():124-134. PubMed ID: 30721703
[TBL] [Abstract][Full Text] [Related]
6. The influence of phenothiazine derivatives on intracellular accumulation of cationic cyanine dye DiOC6(3) in LoVo-DX cells.
Pola A; Mosiadz D; Saczko J; Modrzycka T; Michalak K
Anticancer Res; 2013 Mar; 33(3):857-63. PubMed ID: 23482754
[TBL] [Abstract][Full Text] [Related]
7. Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells.
Wesołowska O; Michalak K; Błaszczyk M; Molnár J; Środa-Pomianek K
Molecules; 2020 Apr; 25(7):. PubMed ID: 32260260
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
[TBL] [Abstract][Full Text] [Related]
9. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
Broggini M; Grandi M; Ubezio P; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1988 Dec; 37(23):4423-31. PubMed ID: 3202888
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
[TBL] [Abstract][Full Text] [Related]
11. Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells.
Kulbacka J; Chwilkowska A; Bar J; Pola A; Banas T; Gamian A; Saczko J
Exp Biol Med (Maywood); 2010 Jan; 235(1):98-110. PubMed ID: 20404024
[TBL] [Abstract][Full Text] [Related]
12. Effect of new oxicam derivatives on efflux pumps overexpressed in resistant a human colorectal adenocarcinoma cell line.
Środa-Pomianek K; Wesołowska O; Szczęśniak-Sięga B; Puła B; Dzięgiel P; Maniewska J; Malinka W; Palko-Łabuz A; Michalak K
Anticancer Res; 2015 May; 35(5):2835-40. PubMed ID: 25964564
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts.
Calcabrini A; Arancia G; Marra M; Crateri P; Befani O; Martone A; Agostinelli E
Int J Cancer; 2002 May; 99(1):43-52. PubMed ID: 11948490
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
15. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
16. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
18. Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.
Radajewska A; Moreira H; Bęben D; Siwiela O; Szyjka A; Gębczak K; Nowak P; Frąszczak J; Emhemmed F; Muller CD; Barg E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298495
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms.
Locatelli L; Cazzaniga A; Fedele G; Zocchi M; Scrimieri R; Moscheni C; Castiglioni S; Maier JA
Curr Issues Mol Biol; 2021 May; 43(1):163-175. PubMed ID: 34067290
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells.
Palko-Labuz A; Sroda-Pomianek K; Uryga A; Kostrzewa-Suslow E; Michalak K
Biomed Pharmacother; 2017 Apr; 88():232-241. PubMed ID: 28110189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
